Abstract:Background: The GABRA1 gene, encoding the GABR A R subunit α1, plays vital roles in inhibitory neurons. Previously, the GABRA1 gene has been identified to be associated with developmental and epileptic encephalopathy (DEE) and idiopathic generalized epilepsy (IGE). This study aims to explore the phenotypic spectrum of GABRA1 and molecular subregional effect analysis. Methods: Trios-based whole-exome sequencing was performed in patients with epilepsy. Previously reported GABRA1 mutations were systematically reviewed to analyze the molecular subregional effects. Results: De novo GABRA1 mutations were identified in six unrelated patients with heterogeneous epilepsy, including three missense mutations (p.His83Asn, p.Val207Phe, and p.Arg214Cys) and one frameshift mutation (p.Thr453Hisfs*47). The two missense mutations, p.His83Asn and p.Val207Phe, were predicted to decrease the protein stability but no hydrogen bond alteration, with which the two patients also presented with mild genetic epilepsy with febrile seizures plus and achieved seizure-free status by monotherapy. The missense variant p.Arg214Cys was predicted to decrease protein stability and destroy hydrogen bonds with surrounding residues, which was recurrently identified in three cases with severe DEE. The frameshift variant p.Thr453Hisfs*47 was located in the last fifth residue of the C-terminus and caused an extension of 47 amino acids, with which the patients presented with moderated epilepsy with generalized tonic-clonic seizures alone (GTCA) but achieved seizure-free status by four drugs. The four variants were not presented in gnomAD and were evaluated as "pathogenic/likely pathogenic" according to ACMG criteria. Analysis of all reported cases indicated that patients with mutations in the N-terminal extracellular region presented a significantly higher percentage of FS and DEE, and the patients with variants in the transmembrane region presented earlier seizure onset ages. Significance: This study suggested that GABRA1 variants were potentially associated with a spectrum of epilepsies, including EFS+, DEE, and GTCA. Phenotypic severity may be associated with the damaging effect of variants. The molecular subregional effects help in understanding the underlying mechanism of phenotypic variation.

Gaba(A) Receptor Mutations Associated with Generalized Epilepsies

GABAA receptor epilepsy mutations

Mutations Linked to Generalized Epilepsy in Humans Reduce GABA(A) Receptor Current.

GABA(A) Receptor Subunit (γ2, δ, β1-3) Variants in Genetic Epilepsy: A Comprehensive Summary of 206 Clinical Cases

Association Analysis of Gamma 2 Subunit of Gamma-Aminobutyric Acid (gaba) Type A Receptor and Voltage-Gated Sodium Channel Type Ii Alpha-Polypeptide Gene Mutation in Southern Chinese Children with Febrile Seizures

Altered Inhibitory Synapses in De Novo GABRA5 and GABRA1 Mutations Associated with Early Onset Epileptic Encephalopathies.

GABA A Receptor Coupling Junction and Pore GABRB3 Mutations Are Linked to Early-Onset Epileptic Encephalopathy

Genetic and Molecular Regulation of Extrasynaptic GABA-A Receptors in the Brain: Therapeutic Insights for Epilepsy

GABRG2 mutations in genetic epilepsy with febrile seizures plus: structure, roles, and molecular genetics

Advance in Molecular Genetic Research on Generalized Epilepsies

Shifting Focus: The "Other" GABAR

GABRG2 Deletion Linked to Genetic Epilepsy with Febrile Seizures Plus Affects the Expression of GABA A Receptor Subunits and Other Genes at Different Temperatures

[Advance in Genetic Study for Idiopathic Generalized Epilepsy].

Genetic Variations in GABA Metabolism and Epilepsy.

De novo GABRA1 variants in childhood epilepsies and the molecular subregional effects

New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System

<i>GABRG2</i> Variants Associated with Febrile Seizures

Dravet Syndrome-Associated Mutations in GABRA1, GABRB2 and GABRG2 Define the Genetic Landscape of Defects of GABAA Receptors

De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy

Astrocytic GABA Transporter 1 Deficit in Novel SLC6A1 Variants Mediated Epilepsy: Connected from Protein Destabilization to Seizures in Mice and Humans.

Altered Channel Conductance States and Gating of GABAA Receptors by a Pore Mutation Linked to Dravet Syndrome